V. Leroy, C. Sakarovitch, M. Cortina-borja, J. Mcintyre, H. Coovadia et al., Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS, pp.191865-1875, 2005.

M. Newell, H. Coovadia, C. Borja, M. Rollins, N. Gaillard et al., Dabis F: Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis, Lancet, issue.9441, pp.3641236-1243, 2004.

S. Blanche, M. Tardieu, A. Duliege, C. Rouzioux, L. Deist et al., Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms, Am J Dis Child, issue.11, pp.1441210-1215, 1990.

R. Spira, P. Lepage, P. Msellati, P. Van-de-perre, V. Leroy et al., Natural history of HIV type 1 infection in children: a five-year prospective study in Rwanda, Pediatrics, vol.104, pp.1-9, 1999.

F. Dabis, N. Elenga, N. Méda, V. Leroy, I. Viho et al., 18-Month mortality and perinatal exposure to zidovudine in West Africa, AIDS, vol.15, issue.6, pp.771-779, 2001.
DOI : 10.1097/00002030-200104130-00013

S. Lucas, C. Peacock, A. Hounnou, K. Brattegaard, K. Koffi et al., Disease in children infected with HIV in Abidjan, Cote d'Ivoire, BMJ, vol.312, issue.7027, pp.335-338, 1996.
DOI : 10.1136/bmj.312.7027.335

S. Graham, Non-tuberculosis opportunistic infections and other lung diseases in HIVinfected infants and children, Int J Tuberc Lung Dis, vol.9, issue.6, pp.592-602, 2005.

S. Wiktor, M. Sassan-morokro, A. Grant, L. Abouya, K. J. Maurice et al., Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, C??te d'Ivoire: a randomised controlled trial, The Lancet, vol.353, issue.9163, pp.1469-1475, 1999.
DOI : 10.1016/S0140-6736(99)03465-0

X. Anglaret, G. Chêne, A. Attia, S. Toure, S. Lafont et al., Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C??te d'Ivoire: a randomised trial, The Lancet, vol.353, issue.9163, pp.1463-1468, 1999.
DOI : 10.1016/S0140-6736(98)07399-1

J. Mermin, J. Lule, J. Ekwaru, S. Malamba, R. Downing et al., Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda, The Lancet, vol.364, issue.9443, pp.3641428-1434, 2004.
DOI : 10.1016/S0140-6736(04)17225-5

C. Chintu, G. Bhat, A. Walker, V. Mulenga, F. Sinyinza et al., Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial, The Lancet, vol.364, issue.9448, pp.3641865-1871, 2004.
DOI : 10.1016/S0140-6736(04)17442-4

F. Dabis, L. Bequet, D. Ekouevi, I. Viho, F. Rouet et al., Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission, AIDS, vol.19, issue.3, pp.309-318, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00193079

V. Leroy, D. Ekouevi, R. Becquet, I. Viho, L. Dequae-merchadou et al., 18-Month Effectiveness of Short-Course Antiretroviral Regimens Combined with Alternatives to Breastfeeding to Prevent HIV Mother-to-Child Transmission, PLoS ONE, vol.192, issue.2, p.1645, 2008.
DOI : 10.1371/journal.pone.0001645.t005
URL : https://hal.archives-ouvertes.fr/inserm-00206136

F. Rouet, C. Montcho, C. Rouzioux, V. Leroy, P. Msellati et al., Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay, AIDS, vol.15, issue.14, pp.1849-1856, 2001.
DOI : 10.1097/00002030-200109280-00015

F. Rouet, D. Ekouevi, M. Chaix, M. Burgard, A. Inwoley et al., Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.432709-2717, 2005.
DOI : 10.1128/JCM.43.6.2709-2717.2005

F. Dabis, P. Msellati, N. Meda, C. Welffens-ekra, B. You et al., 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in C??te d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial, The Lancet, vol.353, issue.9155, pp.786-7922050, 1999.
DOI : 10.1016/S0140-6736(98)11046-2

N. Meda, V. Leroy, I. Viho, P. Msellati, S. Yaro et al., Dabis F: Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa, AIDS, issue.17, pp.162323-2328, 2002.

R. Becquet, D. Ekouevi, I. Viho, C. Sakarovitch, H. Toure et al., Acceptability of exclusive breast-feeding with early cessation to prevent HIV transmission through breast milk, ANRS 1201/1202 Ditrame Plus, pp.40600-608, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00189796

V. Leroy, C. Sakarovitch, I. Viho, R. Becquet, D. Ekouevi et al., Acceptability of Formula-Feeding to Prevent HIV Postnatal Transmission, Abidjan, C??te d??Ivoire, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.44, issue.1, pp.77-86, 2007.
DOI : 10.1097/01.qai.0000243115.37035.97

S. Ivoirienne-de-pathologie-infectieuse and . Tropicale, Première Conférence de Consensus en thérapeutique anti-infectieuse. Cotrimaxazole en prophylaxie primaires des infections opportunistes chez les patients infectés par le VIH en Côte d'Ivoire, 1999.

F. Rouet, C. Sakarovitch, P. Msellati, N. Elenga, C. Montcho et al., Pediatric Viral Human Immunodeficiency Virus Type 1 RNA Levels, Timing of Infection, and Disease Progression in African HIV-1-Infected Children, PEDIATRICS, vol.112, issue.4, pp.289-297, 2003.
DOI : 10.1542/peds.112.4.e289

V. Leroy, J. Karon, A. Alioum, E. Ekpini, P. Van-de-perre et al., Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa, AIDS, vol.17, issue.10, pp.171493-1501, 2003.
DOI : 10.1097/00002030-200307040-00010

V. Leroy, J. Karon, A. Alioum, E. Ekpini, N. Méda et al., Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa National Department of Health, Medical Research Council: Measure DHS, 1998 South Africa demographic and health survey 32. Sinkala M: No benefit of early cessation of breastfeeding at 4 months on HIV-free survival of infants born to HIV-infected mothers in Zambia: the Zambia Exclusive Breastfeeding Study 74; 2007. 33. World Health Organisation: WHO HIV and Infant feeding technical consultation held on behalf of the inter-agency task team (IATT) on prevention of HIV infections in pregnant women, mothers, and their infants. Consensus statement, Fourteenth Conference on Retroviruses and Opportunistic Infections Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children, pp.631-6415, 2002.

H. Zar, A. Dechaboon, D. Hanslo, P. Apolles, K. Magnus et al., Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus, The Pediatric Infectious Disease Journal, vol.19, issue.7, pp.603-607, 2000.
DOI : 10.1097/00006454-200007000-00004

D. Ruffini and S. Madhi, The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia, AIDS, vol.16, issue.1, pp.105-112, 2002.
DOI : 10.1097/00002030-200201040-00013

A. Coutsoudis, K. Pillay, E. Spooner, H. Coovadia, L. Pembrey et al., Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa, S Afr Med J, issue.5, pp.95339-345, 2005.

J. Boerma, K. Stanecki, M. Newell, C. Luo, M. Beusenberg et al., Monitoring scale-up of antiretroviral therapy programmes, Bulletin of the World Health Organization, vol.84, issue.2, pp.145-150838, 2006.
DOI : 10.2471/BLT.05.025189

A. Faye, L. Chenadec, J. Dollfus, C. Thuret, I. Douard et al., Early versus Deferred Antiretroviral Multidrug Therapy in Infants Infected with HIV Type 1, Clinical Infectious Diseases, vol.39, issue.11, pp.391692-1698, 2004.
DOI : 10.1086/425739

E. Chiappini, L. Galli, P. Tovo, C. Gabiano, G. Gattinara et al., Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection., AIDS, vol.20, issue.2, pp.207-215, 2006.
DOI : 10.1097/01.aids.0000200529.64113.3e

M. Newell, D. Patel, T. Goetghebuer, and C. Thorne, CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?, J Infect Dis, vol.193, issue.7, pp.954-962, 2006.

. Violari, ART initiated before 12 weeks reduces early mortality in young children HIV-infected infants : evidence from the children with HIV Early Antiretroviral Therapy (CHER) Study, In IAS, 2007.